- ranked # 13 on the list -
BELLEVILLE, ON, Jan. 14 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 13 by its employees.
The rankings are primarily determined using the results from employee opinion surveys, where 18 key engagement drivers are detailed and analyzed. The evaluation process also includes the assessment of organization practices and perspectives from the leadership team. This year, more than 250 companies across Canada registered to participate in the study.
"We are proud to be selected one of the top small and medium employers in Canada by our employees, particularly as this is our first time participating in this process," said Graeme McRae, Chairman, President & CEO of Bioniche Life Sciences Inc. "Our employees, who are also shareholders in the Company, are our greatest asset. We appreciate their ongoing support and dedication."
Becoming a Top Best Small and Medium Employer is a very detailed and competitive process. This national awards program recognizes top employers with between 50 and 400 employees. This study mirrors the renowned Best Employer in Canada initiative run by partner, Hewitt Associates; however, caters to smaller businesses. The study, now in its fifth year, is published in the Globe and Mail.
Study partners include Queen's School of Business, Queen's Centre for Business Venturing and Hewitt Associates. More information about the Best Small & Medium Employers in Canada is available online at http://business.queensu.ca/qcbv/sme.
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. Bioniche has been named one of Canada's Top Ten Life Sciences Companies for 2008. For more information, please visit www.Bioniche.com.
Except for historical information, this news release may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.
|SOURCE Bioniche Life Sciences Inc.|
Copyright©2009 PR Newswire.
All rights reserved